
Stivcuf SI 15mg/50mg/2.5mg Tablet
Marketer
Indoscot Healthcare LLP
Salt Composition
Ambroxol (15mg) + Guaifenesin (50mg) + Terbutaline (2.5mg)
Overview Stivcuf SI 15mg/50mg/2.5mg Tablet
Respiclear Triple Action 15mg/50mg/2.5mg tablets are indicated for the management of productive coughs. The medication works by liquefying and thinning phlegm in the respiratory tract, facilitating its expulsion. It also promotes bronchodilation, easing breathing difficulties. Respiclear Triple Action tablets are administered orally, with or without food, as directed by your physician. Dosage is individualized based on your condition and response. Continue the prescribed course of treatment; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions may occur. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal pain, dyspepsia, headache, skin rash, palpitations, tremors, and tachycardia. Most resolve spontaneously. Seek immediate medical attention for any concerning side effects. Drowsiness is a potential side effect; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Self-medication and recommending this medication to others are strongly discouraged. Adequate hydration is recommended during treatment. Pregnant or breastfeeding women, and individuals with hepatic or renal impairment, should consult their physician before initiating treatment to ensure appropriate dosage.
Uses of Stivcuf SI 15mg/50mg/2.5mg Tablet
Productive cough
Major Benefits of Stivcuf SI 15mg/50mg/2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Stivcuf SI 15mg/50mg/2.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, but consistent timing is recommended.
Common Side effects of Stivcuf SI 15mg/50mg/2.5mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Headache
- Rash
- Tremors
- Increased heart rate
- Indigestion
- Bloating
- Upper abdominal pain
- Urticaria
- Itching
- Sweating
- Changes in serum aminotransferase levels
How to use Stivcuf SI 15mg/50mg/2.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Stivcuf SI 15mg/50mg/2.5mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or not, although consistent timing is recommended.
How Stivcuf SI 15mg/50mg/2.5mg Tablet works:
Each Stivcuf SI tablet (15mg/50mg/2.5mg) combines ambroxol, guaifenesin, and terbutaline to alleviate coughs accompanied by phlegm.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Stivcuf SI 15mg/50mg/2.5mg Tablet is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Stivcuf SI 15mg/50mg/2.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Stivcuf SI 15mg/50mg/2.5mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Stivcuf SI 15mg/50mg/2.5mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Stivcuf SI 15mg/50mg/2.5mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Caution is advised when prescribing Stivcuf SI 15mg/50mg/2.5mg Tablet to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended. Data regarding the use of Stivcuf SI 15mg/50mg/2.5mg Tablet in such patients remains limited.
What if you forget to take Stivcuf SI 15mg/50mg/2.5mg Tablet :
Should you forget a Stivcuf SI 15mg/50mg/2.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stivcuf SI 15mg/50mg/2.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
